Approach to the patient with diabetes undergoing a vascular or interventional procedure

Journal of Vascular and Interventional Radiology

Volumn 8, Issue 3, 1997, Pages 329-336

  Hirsch, Irl B ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes

Indexed keywords

ACARBOSE; ACETOHEXAMIDE; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORPROPAMIDE; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; INSULIN; INSULIN LISPRO; INSULIN ZINC SUSPENSION; METFORMIN; SULFONYLUREA DERIVATIVE; TOLAZAMIDE; TOLBUTAMIDE;

CORONARY ARTERY BYPASS GRAFT; DIABETIC ANGIOPATHY; DIABETIC KETOACIDOSIS; DRUG ABSORPTION; DRUG FORMULATION; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KINESIOTHERAPY; LACTIC ACIDOSIS; LASER SURGERY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; WEIGHT REDUCTION;

EID: 0030809802     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(97)70567-0     Document Type: Article

References (43)

1. Harris MI. Summary (Chapter 1). In: Diabetes in America. 2nd ed. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIH Publication No. 95-1468, 1995; 1-13.
2. Rubin RJ, Altman WM, Mendelson DN. Health-care expenditures for people with diabetes mellitus. J Clin Endocrinol Metab 1994; 78: 809a-809f.
3. Ray NF, Wills S, Thamer M. Direct and indirect costs of diabetes in the United States in 1992. American Diabetes Association, Alexandria, VA, 1993.
4. Jacobs J, Sena M, Fox N. The cost of hospitalization for the late complications of diabetes in the United States. Diabetic Med 1991; 8:S23-S29.
5. Helms RB. Implications of population growth on prevalence of diabetes. Diabetes Care 1992; 15(suppl 1):6-9.
6. American Diabetes Association. Diabetes 1993 Vital Statistics. American Diabetes Association, Alexandria, VA; 1993.
7. Winegard DL, Barrett-Connor E. Heart disease and diabetes (Chapter 19). In: Diabetes in America. 2nd ed. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIH Publication No. 95-1468, 1995; 429-148.
8. Palumbo PJ, Melton LG III. Peripheral vascular disease and diabetes (Chapter 17). In: Diabetes in America. 2nd ed. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIH Publication No. 95-1468, 1995; 401-408.
9. Fujimoto WY. Can NIDDM be prevented? The Diabetes Prevention Program. Practical Diabetology 1996; 15:10-15.
10. Position Statement. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1996; 19(suppl 1):S8-S15.
11. Yudkin JS. How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. Br Med J 1993; 306:1313-1318.
12. Chew EY, Klein ML, Murphy RP, Remaley NA, Ferris FL III. Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus. Early Treatment Diabetes Retinopathy Study report no. 20. Arch Ophthalmol 1995; 113:52-55.
13. Jonas M, Reicher-Reiss H, Boyko V, et al. Usefulness of beta-blocker therapy in patients with non-insulin-depependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group. 1996; Am J Cardiol 77:1273-1277.
14. Lynch M, Gammage MD, Lamb P, Nattrass N, Pentecost L. Acute myocardial infarction in the thrombolytic era. Diabetic Med 1994; 11:162-165.
15. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerence. Diabetes 1979; 28:1039-1057.
16. Zimmet PZ. The pathogenesis and prevention of diabetes in adults: genes, autoimmunity, and demography. Diabetes Care 1995; 18:1050-1064.
17. Warram JH, Rich SS, Krolewski AS. Epidemiology and genetics of diabetes mellitus (Chapter 12). In: Kahn CR, Weir GC, eds. Joslin's diabetes mellitus. 13th ed. Philadelphia: Lea & Febiger, 1994; 201-215.
18. Elks ML, Sawyer JW Jr. Misunderstanding in the classification of diabetes mellitus. What's in a name? West J Med 1993; 159:44-49.
19. Bailey CJ, Turner RC. Drug therapy: metformin. N Engl J Med 1996; 9:574-579.
20. Sirtori CR, Pasik C. Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacol Res 1994; 30:187-228.
21. Krentz AJ, Ferner RE, Bailey CJ. Comparative tolerability profile of oral antidiabetic agents. Drug Saf 1994; 11:223-241.
22. Clark CM, Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 1995; 332:1210-1217.
23. Hirsch IB. Surveillance for complications of diabetes. Postgrad Med 1996; 99:147-162.
24. Molitch ME. ACE inhibitors and diabetic nephropathy. Diabetes Care 1994; 17:756-760.
25. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331:1416-1420.
26. Billström A, Hietala SO, Lithner F, Merikanto J, Wirell M, Wirell S. Nephrotoxicity of contrast media in patients with diabetes mellitus. Acta Radiol 1989; 30:509-514.
27. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med 1989; 320:143-149.
28. Albrectsson U, Hultverg B, Larudottir H, Norgren L. Nephrotoxicity of ionic and non-ionic contrast media in aorto-femoral angiography. Acta Radiol Diagn 1985; 26: 615-618.
29. Apelqvist J, Torffvit O, Agardh CD. The effect of the non-ionic contrast medium iohexol on glomerular and tubular function in diabetic patients. Diabetic Med 1996; 13:487-492.
30. Dachman AH. New contraindication to intravascular iodinated contrast material (letter). Radiology 1995; 197:545.
31. Rotter MD. New contraindication to intravascular iodinated contrast material (letter). Radiology 1995; 197:545-546.
32. Innerfield RJ. Metformin-associated mortality in U.S. studies (letter). N Engl J Med 1995; 333: 1611-1612.
33. Gueriguian J, Green L, Misbin RO, Stadel B, Fleming GA. Efficacy of metformin in non-insulin-dependent diabetes mellitus (letter). N Engl J Med 1996; 334:269-270.
34. Pond GD, Smyth SH, Roach DI, Hunter G. Metformin and contrast media: genuine risk or witch hunt? Radiology 1996; 201:879-880.
35. Stadel BV, Gueriguian JJ, Fleming GA. Metformin-associated mortality in U.S. studies (letter). N Engl J Med 1996; 334:1613.
36. Hirsch IB, Paauw DS, Brunzell J. Inpatient management of adults with diabetes. Diabetes Care 1995; 18:870-879.
37. Siegler DE, Olsson GM, Skyler JS. Morning vs bedtime isophane insulin in type 2 (non-insulin dependent) diabetes mellitus. Diabetic Med 1992; 9:826-833.
38. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR. [Lys(B28), Pro(B29)]-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 1994; 43:396-402.
39. Anderson JH, Brunelle RL, Vignati L. Insulin lispro compared to regular insulin in a crossover study involving 1037 patients with type I diabetes. Diabetes 1995; 44(suppl 1):228A.
40. Hirsch IB, McGill JB. Role of insulin in management of surgical patients with diabetes mellitus. Diabetes Care 1990; 13:980.
41. Husband DJ, Thai AC, Alberti KGMM. Management of diabetes during surgery with glucose-insulin-potassium infusion. Diabetic Med 1986; 3:69-74.
42. Werb MR, Zinman B, Teasdale SJ, Goldman BS, Skully HE, Marliss EB. Hormone and metabolic responses during coronary artery bypass surgery: role of infused glucose. J Clin Endocrinol Metab 1989; 69:1010-1018.
43. Groop LC, Pelkonen R, Koskimies S, Botazzo GF, Doniach D. Secondary failure to treatment with oral antidiabetic agents in non-insulin dependent diabetes mellitus. Diabetes Care 1986; 9:129-133.